6 documents found, page 1 of 1
Clinical and molecular characterisation of metastatic papillary thyroid cancer ...
Simões-Pereira, Joana; Saramago, Ana; Rodrigues, Ricardo; Pojo, Marta; Pires, Carolina; Horta, Mariana; López-Presa, Dolores; Rito, MiguelFunding Information: This study was funded by iNOVA4Health Research Unit (LISBOA-01-0145-FEDER-007344; UID/Multi/00462; UIDB/04462/2020), a program co-funded by Fundação para a Ciência e Tecnologia/Ministério da Ciência e do Ensino Superior, Sociedade Portuguesa de Endocrinologia, Diabetes e Metabolismo (SPEDM), and Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG). J.S.-P. was supported by i...
Validation of the SCORE2 risk prediction algorithm in a Portuguese population
Temtem, Margarida; Mendonça, Maria Isabel; Santos, Marina; Sá, Débora; Sousa, Francisco; Freitas, Sónia; Borges, Sofia; Henriques, EvaPublisher Copyright: © 2024 Sociedade Portuguesa de Cardiologia; Introduction and Objectives: Subjects without cardiovascular (CV) disease (CVD) may suffer from subclinical atherosclerosis, and are at increased risk for atherosclerotic CV events (ASCVE). The ESC/EAS risk SCORE was updated by SCORE2, which estimates 10-year risk of fatal and non-fatal CVD in European populations aged 40–69 years without establis...
Target therapy for BRAF mutated anaplastic thyroid cancer
da Silva, Tiago Nunes; Rodrigues, Ricardo; Saramago, Ana; Pires, Carolina; Rito, Miguel; Horta, Mariana; Martins, Carmo; Leite, ValerianoFunding This work was funded by Fundação para a Ciência e Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES, Portugal) through national funds to iNOVA4Health (UIDB/04462/2020 and UIDP/04462/2020) and the Associated Laboratory LS4FUTURE (LA/P/0087/ 2020), by Associação de Endocrinologia Oncológica (AEO), and by Instituto Português de Oncologia de Lisboa Francisco Gentil (IPOLFG). Carolina...
Outcomes of lenvatinib therapy in poorly differentiated thyroid carcinoma
Roque, João; Silva, Tiago Nunes; Regala, Catarina; Rodrigues, Ricardo; Leite, ValerianoFunding Information: Ricardo Rodrigues was granted with a PhD scholarship by iNOVA4Health Research Unit (UIDP/04462/2020; UI/BD/154256/2022). The remaining authors did not receive any specific grant from funding agencies in the public, commercial, or non-for-profit sectors. Publisher Copyright: © 2023 the author(s) Published by Bioscientifica Ltd.; Background and objective: Lenvatinib showed promising results i...
SPRY4 as a Potential Mediator of the Anti-Tumoral Role of Macrophages in Anapla...
Pinto, Ana Teresa; Pojo, Marta; Rodrigues, Ricardo; Sousa, Diana Pacheco; Matthiesen, Rune; Carvalho, Ana Sofia; Beck, Hans C.; Pires, CarolinaFunding Information: This work was funded by MERCK in collaboration with Grupo de Estudos da Tiroide (GET) from Sociedade Portuguesa de Endocrinologia Diabetes e Metabolismo (SPEDM) (MERCK/GET/SPEDM/2017), by Fundação para a Ciência e Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior (FCT/MCTES, Portugal) through national funds to iNOVA4Health (UIDB/04462/2020 and UIDP/04462/2020) and the Associate...
Metastatic follicular thyroid cancer with a longstanding responsiveness to gemc...
Dias, Daniela; Damásio, Inês; Marques, Pedro; Simões, Helder; Rodrigues, Ricardo; Cavaco, Branca Maria; Leite, ValerianoFunding Information: Ricardo Rodrigues is a recipient of a PhD scholarship by iNOVA4Health Research Unit (UIDP/04462/2020; UI/BD/154256/2022), a program co-funded by Fundação para a Ciência e a Tecnologia, Portugal, and by Ministério da Ciência e do Ensino Superior, Portugal. This work was funded by Associação de Endocrinologia Oncológica (AEO) and by Instituto Português de Oncologia de Lisboa Francisco Gentil ...